Related Articles
CYTODIFFERENTIATION INDUCERS AS ANTICANCER AGENTS (REVIEW)
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Molecular mechanisms of chemoresistance in osteosarcoma (Review)
FENRETINIDE IN BREAST-CANCER CHEMOPREVENTION (REVIEW)
CELL-MEDIATED-IMMUNITY AND IMMUNOTHERAPY IN OVARIAN-CANCER (REVIEW)